Men could therefore be wasting money on expensive treatments. According to paid pharmaceutical claims outlined in the 2016 Medicare Part D Drug Claims database cited by the researchers,testosterone replacement therapy cost an annual $2,135.32 per beneficiary in 2016, and $156.24 for the intramuscular formulation.the organization decided to assess testosterone replacement treatments as they kept popping up in discussions among its Clinical Guidelines Committee.
McClean said he would advise patients who claim such treatments have a positive effect on their well-being, aside from sexual function, to consider stopping. "Evidence shows there is no significant evidence for long-term benefit or harm so there would be no concern that stopping such supplements would have an adverse effect," he said.
"In this era with so much information being available online, it can be very challenging for patients to distinguish evidence-based information from unscientific claims," McLean continued. "Bias and conflicts of interest are everywhere, and both patients and physicians need to look at information and be willing to look beneath the surface at the process and underlying financial support when making decisions about validity," he said, adding:"Relying on the internet for one's health advice is extremely risky and not recommended."